Timing: Inject on consistent days each week and rotate injection sites systematically
Standard clinical dose escalation The FDA-approved Mounjaro (brand tirzepatide) follows this schedule: Weeks 1-4: 2.5 mg once weekly (starting dose, allows GI adaptation) Weeks 5-8: 5 mg once weekly (first therapeutic dose increase) Weeks 9-12: 7.5 mg once weekly (if tolerated and additional effect needed) Weeks 13-16: 10 mg once weekly (continued escalation) Weeks 17-20: 12.5 mg once weekly (approaching maximum) Week 21+: 15 mg once weekly (maximum approved dose) Each dose is maintained for at least four weeks before escalation
J Bioenerg Biomembr 39:6572 Nguyen KT (2011) Targeted nanoparticles for cancer therapy: promises and challenge
Aboukhater D, Morad B, Nasrallah N, Nasser SA, Sahebkar A, Kobeissy F, Boudaka A, Eid AH
The Critical Importance of BPC-157 in Modern Research BPC-157 is not merely a compound
10 Mechanistic model of KL1 -mediated sensitization of intracellular S